or
forgot password

Prospective Evaluation of Robot-Assisted Surgery in Gynecologic Oncology


N/A
N/A
N/A
Open (Enrolling)
Female
Gynecologic Cancer

Thank you

Trial Information

Prospective Evaluation of Robot-Assisted Surgery in Gynecologic Oncology


Information Collection:

If you agree to take part in this study, the following information will be collected from
your medical record after surgery:

- The reason you had or are scheduled to have robot-assisted surgery.

- How long the surgery took to complete.

- What procedures were performed during the surgery.

- If cancer was or was not found in the tissue that was removed.

- How long you were in the hospital.

- What complications, if any, happened that are related to the surgery.

Follow-Up Questionnaires:

Depending on when you enroll in the study, you may be asked to complete a short
questionnaire 3 different times, each questionnaire will take less than 10 minutes to
complete. If you had surgery for cervical cancer, you will complete the questionnaire 2
weeks after surgery. All patients will complete the questionnaires 4-6 weeks after surgery,
and again 3-6 months later.

If you have your follow up care with a doctor outside of MD Anderson, you will be called to
complete the questionnaires over the phone. Each phone call should last about 10 minutes
This questionnaire and/or phone calls will ask questions about any side effects you have
experienced that you think may be related to the surgery.

Length of Study:

After the last questionnaire is completed, your participation in the study is over.

This is an investigational study. There will be no cost to you for taking part in the
study.

Up to 1,000 patients will take part in this study at MD Anderson Cancer Center, Banner MD
Anderson Arizona, and St. Luke's Episcopal Hospital.


Inclusion Criteria:



1) All women who have undergone or will undergo a robotic-assisted gynecologic procedure
at MD Anderson Cancer Center, MD Anderson Banner - Arizona and St. Luke's Episcopal
Hospital are eligible for inclusion in this study. They should be able to speak either
English or Spanish.

Exclusion Criteria:

1) None

Type of Study:

Observational

Study Design:

Observational Model: Case-Only

Outcome Measure:

Data Collection of Surgical Times, Procedures Performed, Intra-operative + Postoperative Complications of Robot-assisted Gynecologic Oncology Cases

Outcome Time Frame:

5 Years

Safety Issue:

No

Principal Investigator

Pamela Soliman, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

M.D. Anderson Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

2008-0122

NCT ID:

NCT00671827

Start Date:

April 2008

Completion Date:

Related Keywords:

  • Gynecologic Cancer
  • Gynecologic Cancer
  • Cervical Cancer
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Ovarian Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer
  • Questionnaire
  • Survey
  • Robot-Assisted Surgery

Name

Location

UT MD Anderson Cancer Center Houston, Texas  77030
St. Luke's Episcopal Hospital Houston, Texas  77030